DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling: DSCR9/miR-21-5p/BTG2 regulates pancreatic cancer

The outcome of pancreatic adenocarcinoma (PAAD) patients is poor, given resistance to gemcitabine. Long noncoding RNA (lncRNA) has been implicated in the carcinogenesis of pancreatic cancer; however, its function and mechanism in PAAD resistance to gemcitabine (GEM) are yet unknown. Herein, we demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui, Li, Xia, Zhang, Xianlin, Li, Zhiqiang, Han, Duo, Gao, Wenzhe, Liu, Ling, Peng, Cheng, Zhu, Hongwei, Yu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157615/
https://www.ncbi.nlm.nih.gov/pubmed/36789695
http://dx.doi.org/10.3724/abbs.2022194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157615/
https://www.ncbi.nlm.nih.gov/pubmed/36789695
http://dx.doi.org/10.3724/abbs.2022194

Ejemplares similares